T2DM Discharge Plan Trial Results with 120 Patients, 2025

120 hospitalized patients with type 2 diabetes mellitus were randomly assigned to intervention and control groups from April to October 2025. The dataset likely contains results from a clinical trial evaluating a four-stage discharge preparation plan, comparing outcomes like discharge readiness scores, glycemic control, and readmission rates. The data was uploaded by Huang Chen on figshare in May 2026.

Use Cases

• Compare discharge readiness scores (RHDS) between intervention and control groups.
• Analyze the impact of a structured discharge plan on glycemic control indicators like fasting blood glucose and HbA1c.
• Evaluate cost-effectiveness based on reported direct medical cost reduction and cost-effectiveness ratios.
• Model the relationship between self-management ability (SDSCA scores) and 3-month readmission rates.

Strengths

• Results include specific statistical outcomes, such as a 5.00% vs. 16.67% 3-month readmission rate.
• The study design involved a randomized controlled trial with 60 patients in each group.
• Health economic metrics are provided, including an average cost reduction of 633.9 yuan per patient.

Limitations

• The dataset is small at 16.6 KB, suggesting limited scope or summary-level data.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Huang Chen via figshare

Collection Method

Randomized controlled trial conducted in a hospital endocrinology department.

Time Range

Patient admission from April 2025 to October 2025; follow-up to 3 months post-discharge.

Freshness

Last updated 2026-05-15 05:41:05